Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
20.07.23
/
50%
€31.22
Target price
20.07.24
€49.32
Performance (%)
-17.26%
End price
21.07.24
€25.83
Summary
This prediction ended on 21.07.24 with a price of €25.83. The price of Arrowhead Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.26%. B__Riley has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 2.573% | 2.573% | -45.953% |
| iShares Core DAX® | -3.352% | -0.947% | 29.388% |
| iShares Nasdaq 100 | -0.740% | 3.167% | 12.756% |
| iShares Nikkei 225® | -1.885% | -0.531% | 3.080% |
| iShares S&P 500 | -0.952% | 2.583% | 7.891% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten
Current prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-35.57%
01.08.25
01.08.25
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.85
14.02.25
14.02.25
€36.16
14.02.26
14.02.26
-27.03%
01.08.25
01.08.25